Anastrozole

Therapeutic indications

Anastrozole is indicated for:

Hormone receptor-positive breast cancer in postmenopausal women

Women only, only Adults (18 years old or older)

Anastrozole is indicated for the:

Treatment of hormone receptor-positive advanced breast cancer in postmenopausal women.
Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women.
Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 1 mg once a day

Contraindications

Active ingredient Anastrozole is contraindicated in the following cases:

Lactation

No gender/age discrimination

There are no data on the use of anastrozole during lactation. Anastrozole is contraindicated during breastfeeding.

Pregnancy

No gender/age discrimination

There are no data from the use of anastrozole in pregnant women. Studies in animals have shown reproductive toxicity. Anastrozole is contraindicated during pregnancy.

< Previous: Overview

Precautions: Next >